A Follow-up Study With Children Who Participated in the TEMPO Study in Their First Year of Life

Sponsor
Nutricia Research
Study ID
NCT05449756
Status
Recruiting
Apply to this trial

Conditions

  • Allergy
  • Infections

Eligibility Criteria

Sex
ALL
Age
3 Years - 10 Years
Healthy Volunteers
Accepted

Interventions

  • Self-administered questionnaires — OTHER
    Three-monthly self-administered digital questionnaires (accessed on smartphone, tablet or computer)

Study Details

This is a follow-up study of a randomised clinical trial, called TEMPO (a double-blind randomized clinical trial investigating infant formula and human breast milk consumption), in which infants participated in their first year of life. The investigators like to know if these children develop allergies or infections in childhood and whether their feeding pattern in infancy plays a role.

Key Dates

First listed
Jul 8, 2022
Start date
May 30, 2023
Status verified
Dec 2023
Primary completion
Mar 31, 2029
Completion
Mar 31, 2029

Study Design

Enrollment
705 participants (estimated)

Arms

  • Arm: Children who participated in randomised clinical trail, called TEMPO, in their first year of life
    Children who participated in randomised clinical trail, called TEMPO, in their first year of life

Primary Outcome Measure

Parent-reported symptoms of allergies and infections [ Time Frame: 7.5 years ]

Central Contacts

Related Studies